Heyao Biotechnology (Nanjing) Co., Ltd. is a high-tech enterprise centered on AI-driven synthetic biology. Its founding team comprises overseas-trained scientific experts and management professionals, possessing extensive experience in synthetic biology R&D and industrial implementation. The company has established a comprehensive infrastructure for R&D, production, and support services, featuring high-standard automated R&D laboratories in Beijing and Nanjing, alongside an intelligent biomanufacturing plant in Chuzhou, creating a dual-hub R&D network that bridges the north and south.

Guided by the ultimate vision of "AI + Synthetic Biology accelerating humanity's transition to a world free from hunger and aging" and the development philosophy of "creating a better, sustainable life for humanity through technology," the company deeply integrates artificial intelligence with synthetic biology. It has built a dual-engine platform combining "full-industry-chain technical solutions" with "green biomanufacturing."

The company focuses on developing green biomanufacturing processes and targets two key sectors: beauty & health and food security. With the core objective of researching and mass-producing sustainable bio-based products, it has independently established three core technology platforms—an AI+Synbio biological modification platform, an intelligent protein engineering design platform, and an intelligent automated experimentation platform. By integrating in-house capabilities across the entire value chain—from strain modification and biosynthesis to efficacy validation—the company provides comprehensive technical solutions for fundamental raw material upgrades. It addresses critical challenges in industrial sustainability and fosters a new biomanufacturing ecosystem characterized by high quality, green practices, and low-carbon operations.